Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04175691

Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)

AISRNA is to analyze the expression pattern of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with acute ischemic stroke and healthy control. The candidate circRNA/miRNA/lncRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Noncoding RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the expression pattern of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with acute ischemic stroke and healthy control. The candidate circRNA/miRNA/lncRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke. Distinctive expression patterns of circRNA/miRNA/lncRNA will be identified by the next-generation sequencing and individual quantitative real time polymerase chain reaction (qRT-PCR). A diagnostic or predictive model will be established using logistic regression. The panel of these altered ncRNAs may be associated with acute IS and could serve as a novel diagnostic or predictive method.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years or older
  • Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan
  • Within 72 hours of symptom onset
  • Good performance status
  • Signed an approved informed consents

Exclusion criteria

-a history of hemorrhagic infarction, chronic kidney/liver diseases, peripheral arterial occlusive disease, active malignant disease, and inflammatory or infectious diseases

Treatment and study plan

Sequencing of circRNA/miRNA/lncRNA

Genetic

Next generation sequencing of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA)

Other names: Quantitative Real-time polymerase chain reaction

Primary outcomes

  1. Differential expression pattern of circRNA/miRNA/lncRNA

    Time frame: 90 days

    Differential expression pattern of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA) will be compared between AIS group and HC group, thus candidate circRNA/miRNA/lncRNA will be verified as biomarkers for the detection and prognosis of AIS.

Secondary outcomes

  1. Prognostic value of circRNA/miRNA/lncRNA in acute ischemic stroke

    Time frame: 90 days

    The prognosis of AIS patients will be analyzed between differential expressed candidate miRNA/lncRNA after they have completed the systematic therapy.

  2. Correlation of circRNA/miRNA/lncRNA and inflammatory factors in acute ischemic stroke

    Time frame: 7 days

    Correlation of circRNA/miRNA/lncRNA and inflammatory factors on admission will be explored in acute ischemic stroke.

  3. Correlation of circRNA/miRNA/lncRNA and stroke-associated infection

    Time frame: 30 days

    Correlation of circRNA/miRNA/lncRNA and stroke-associated infection will be explored in acute ischemic stroke.

  4. Dynamic changes of circRNA/miRNA/lncRNA during the follow-up period

    Time frame: 90 days

    Dynamic changes of circRNA/miRNA/lncRNA will be explored before and after endovascular therapy

Study contacts

Contact information is provided by the study sponsor or research team.

Junshan Zhou, M.D.

CONTACT

[email protected]

+8602587726218

Qiwen Deng, M.D.

CONTACT

[email protected]

+8602587726218

Sponsors and collaborators

Lead sponsor

Nanjing First Hospital, Nanjing Medical University

Other

Registry information

Official study title

Clinical Significance of Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)

Acronym: AISRNA

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
Nov 25, 2019
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.